Embecta AID System in Adults With Type 2 Diabetes
← catalyst calendarSponsored by Embecta Corp. (industry) · EMBC — their whole pipeline →. With Jaeb Center for Health Research.
Phase
Not applicable
Status
Withdrawn
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
0actual
Sites
9
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Program was discontinued.
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jan 2025 | estimated | When the study began enrolling |
| Primary completion | Mar 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | May 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2024-11-18 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-12-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Type 2 Diabetes
- Type 2 Diabetes Mellitus (T2DM)
- Type 2 DM
- T2DM With Inadequate Glycemic Control
- T2DM (Type 2 Diabetes Mellitus)
- T2D
- T2DM
Interventions
- Device: An AID System.
- Other: Standard of Care (SC)
Primary outcome
what the primary-completion date above is the date OFHbA1c change
measured 13 weeks
Permalink · EMBC's whole pipeline · Catalyst calendar · Every registered study · What changed